This indicates that the underlying mechanisms—reduced insulin levels, enhanced lipolysis, and improved lipoprotein particle profiles—may extend to metabolic disturbances beyond T2DM, making low-carbohydrate dietary interventions relevant for a variety of endocrine and metabolic disorders. The gene discussed is INS; the disease is metabolic disease.